Tag: generic market entry

Recent Patent Cases and Generic Delays: 2023-2025 Examples

Despite FDA approval, many generic drugs face multi-year delays due to patent litigation. Between 2023 and 2025, patent thickets extended monopolies by an average of 3.7 years, costing patients billions and creating widespread drug shortages.